New York City, New York Mar 27, 2025 (Issuewire.com) - Healthcare 360 Magazine, a premier B2B publication, has spotlighted NeOnc Technologies Holdings in its recent issue, highlighting the company's groundbreaking work in overcoming the blood-brain barrier for transformative CNS therapies. This feature underscores NeOnc's pivotal role in pioneering advanced drug delivery solutions.

This issue, Trailblazers in Healthcare Innovation: NASDAQ Visionaries 2025, explores groundbreaking advancements in overcoming the blood-brain barrier (BBB) to enhance drug delivery. It highlights the innovative efforts of companies and researchers developing new strategies to deliver therapies to the central nervous system (CNS), transforming the treatment of neurological disorders.

About NeOnc technologies Holdings

Founded by Dr. Chen, whose expertise in oncology and neuroscience fueled groundbreaking research at USC Keck Medical School, NeOnc Technologies strives to solve the blood-brain barrier challenge. This mission, aimed at developing life-changing CNS treatments, remains the company's driving force.

What Readers Can Learn from the Cover Story?

• The platform overcomes the blood-brain barrier, improving drug delivery effectiveness for treating brain disorders.
• NeOnc collaborates with academic institutions and pharmaceutical companies to expand its use for a broader range of CNS conditions beyond brain cancer.
• Amir Heshmatpurs leadership has driven the companys success, including advancing clinical trials and securing over 135 patents worldwide
• NeOnc Technologies is leading the way in non-invasive, and precision drug delivery.

About Healthcare 360 Magazine

Dedicated to transforming healthcare understanding, Healthcare 360 Magazine provides a dynamic, global digital space for innovation and inspiration. It delivers cutting-edge information and success stories, empowering healthcare professionals and individuals with transformative ideas.